In a revelation that will shock precisely no one outside of a boardroom at Pfizer, Canadians are reportedly enjoying bargain-bin Ozempic while their American cousins remortgage their houses to afford a single dose. The news, which leaked from a clandestine meeting of Big Pharma executives (held, presumably, in a volcano lair with a shark tank), has sent shockwaves through the diabetes community. Or at least, it would if anyone could afford the internet connection to read about it.
Let us paint you a picture. Picture a Canadian, let's call him 'Maple-Syrup Pete'. Pete strolls into his local pharmacy, hums the national anthem, and emerges with a three-month supply of Ozempic for the price of a poutine and a kind word. Meanwhile, in the good old US of A, a diabetic named 'Medical-Bill Mike' is considering selling a kidney to fund his next prescription. His insurance company, a hydra-headed beast with a legal department larger than most small countries, has decided that his 'pre-existing condition' is actually a 'pre-existing excuse to charge you more'.
But wait, there's more. The UK's NHS, that bastion of socialist healthcare that makes Tory MPs break out in hives, has been praised for its pricing model. Yes, the very same model that allows Britons to complain about the weather while enjoying subsidised pharmaceuticals. The same model that has American healthcare lobbyists weeping into their single-malt Scotch. The NHS, with its charmingly bureaucratic acronym, has somehow managed to negotiate prices that don't require a second mortgage. How? By employing the radical concept that healthcare is a human right, not a luxury item for the wealthy.
Now, before you accuse me of being a commie pinko, let me assure you: I am merely a vessel for the truth, a truth that tastes of cheap gin and smells of desperation. The real scandal here is not that Canadians and Brits get cheaper drugs, it's that Americans are being fleeced by a system that treats illness as an opportunity for profit. It is a system where a diabetic must choose between eating and injecting. A system where the phrase 'life-saving medication' is followed by the words 'out of network'.
This is not journalism. This is a cry from the abyss. This is a world where the CEO of a pharmaceutical company earns more in a minute than a nurse earns in a year. This is a world where a drug that costs pennies to manufacture is sold for thousands. And we, the great unwashed, are expected to smile and pay up.
But fear not, dear reader, for there is hope. The Canadian model, the UK model, these are not myths. They are real, functioning healthcare systems that do not require patients to choose between their health and their savings. Perhaps one day, the land of the free will be free of medical bankruptcy. Until then, I'll be here, nursing a gin and tonic, watching the circus with a weary eye.
This is Biff Thistlethwaite, signing off. Now, if you'll excuse me, I have to go refill my prescription for reality.
